Double-blind, placebo-controlled, dose-ranging study of ramosetron for the prevention of nausea and vomiting after thyroidectomy
- Type
- Retraction
- Notice date
- 5/1/2018 0:00
- Journal
- Clinical Therapeutics
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.clinthera.2018.04.009
- Original paper DOI
- 10.1016/s0149-2918(02)80025-x
Reasons
- Falsification/Fabrication of Data
- Investigation by Company/Institution
- Investigation by Journal/Publisher
- Investigation by Third Party
- Misconduct - Official Investigation(s) and/or Finding(s)
- Misconduct by Author